Go Pro

BTIG Research's Rating of Yarrow Bioscience on 8/3/2026

On August 3, 2026, BTIG Research updated its outlook on Yarrow Bioscience (NASDAQ:YARW) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from BTIG Research

DateCompanyAction
8/5/2026
AC Immune stock logo
ACIU
AC Immune
Reiterated Rating
8/5/2026
Galaxy Digital Inc. stock logo
GLXY
Galaxy Digital
Lower Price Target
8/5/2026
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
Reiterated Rating
8/5/2026
Flutter Entertainment PLC stock logo
FLUT
Flutter Entertainment
Lower Price Target
8/5/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
Boost Price Target
8/5/2026
Workiva Inc. stock logo
WK
Workiva
Lower Price Target
More Ratings From BTIG Research